BSECompany Update7 Oct 2026 · 7 Oct 2026, 01:52 pm
Pls find enclosed Certificate as per Reg 74(5) of SEBI (DP) Regulations.
Ajanta Pharma Ltd · 532331
✦ AI Summary
Ajanta Pharma Ltd has enclosed a Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ajanta Pharma Ltd - 532331 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
bc0bab53-1250-42f2-a7fd-ef3ec43b7f8b.pdf
View document text
Ajanta Pharma Limited
Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000
Road, Chakala, Andheri (E), E legal.info@ajantapharma.com
Mumbai 400 093, India W www.ajantapharma.com
7th October 2026
BSE LIMITED National Stock Exchange of India,
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no.
Dalal Street, C/1, G Block, Bandra Kurla Complex,
Mumbai – 400001 Bandra (East), Mumbai – 400 051
Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ
Sub.: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants)
Regulations, 2018
Dear Sir/Madam,
We are pleased to enclose herewith certificate under Regulation 74(5) of the SEBI
(Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026
received from M/s. MUFG Intime India Private Limited (formerly known as Link Intime India
Private Limited), Registrar and Share Transfer Agent of the Company.
Kindly take the same on your record and oblige.
Yours Faithfully,
GAURANG SHAH
Sr. VP - Legal & Company Secretary
Encl: - As above
Corporate Identity Number - L24230MH1979PLC022059
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400083.
Tel: +91 22 4918 6000
www.in.mpms.mufg.com
Date : 03-10-2026
The Compliance Officer/ Company Secretary
AJANTA PHARMA LIMITED
AJANTA TOWER
54-A
M V ROAD CHAKALA,
ANDHERI (E)- MUMBAI
MUMBAI
PINCODE : 400093
Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and
Participants) Regulations, 2018.
Dear Sir/Madam,
In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for
dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the depositories by us and
that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are
listed.
We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security
certificates received were mutilated and cancelled after due verification by the depository participant and the name of the
depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request
you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
Ashok Shetty
Sr. Vice President-Corporate Registry
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services